Form 8-K/A
8-K/A — DNA X, Inc.
Accession: 0001493152-26-032680
Filed: 2026-07-09
Period: 2026-06-29
CIK: 0001178697
SIC: 3661 (TELEPHONE & TELEGRAPH APPARATUS)
Item: Unregistered Sales of Equity Securities
Item: Material Modifications to Rights of Security Holders
Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item: Other Events
Documents
8-K/A — form8-ka.htm (Primary)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K/A
8-K/A (Primary)
Filename: form8-ka.htm · Sequence: 1
true
--12-31
0001178697
0001178697
2026-06-29
2026-06-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
(Amendment
No. 1)
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): June 29, 2026
DNA
X, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
001-38907
94-3336783
(State
or other jurisdiction
of incorporation)
(Commission
File
Number)
(IRS
Employer
Identification No.)
4445
Eastgate Mall, Suite 200
San
Diego, CA
92121
(Address
of principal executive offices)
(Zip
Code)
Registrant’s
telephone number, including area code: (661) 618-7580
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common
Stock, par value $0.001 per share
SONM
The
Nasdaq Stock Market LLC
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory
Note
This
Current Report on Form 8-K/A amends the Current Report on Form 8-K filed by DNA X, Inc. (the “Company”) with the Securities
and Exchange Commission on July 2, 2026 (the “Original 8-K”). This Form 8-K/A is being filed for the purpose of updating
the disclosure under Items 3.02, 3.03 and 5.03 of the Original 8-K and providing additional information relating to the Transaction under
Item 8.01 hereof.
Item
3.02
Unregistered
Sales of Equity Securities.
On
July 8, 2026, the Company sold and issued an aggregate of 929,864 shares of Series B Preferred Stock in exchange for cash proceeds of
$2.5 million and the cancellation of $3.1 million of the outstanding balance under the convertible promissory note. The Company expects
to consummate the sale and issuance of the remaining 416,667 shares subscribed for under the Purchase Agreement on or prior to August
14, 2026.
Item
3.03
Material
Modification to Rights of Security Holders.
The
information set forth below in Item 5.03 regarding the filing of the Certificate of Designation is incorporated into this Item 3.03 by
reference.
Item
5.03
Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.
The
Company filed the Certificate of Designation with the Secretary of State of the State of Delaware on July 6, 2026.
Item
8.01
Other
Events.
Based
on the foregoing transactions, as of the date of the filing of this Current Report on Form 8-K/A, the Company believes
it has stockholders’ equity in excess of the $2.5 million stockholders’ equity requirement for continued listing
on The Nasdaq Capital Market, as reflected in the pro forma stockholders’ equity balance provided below. The Company is awaiting
Nasdaq’s formal determination that it has evidenced compliance with the minimum stockholders’ equity rule and intends to
provide an update upon receipt of such determination.
To
provide additional information regarding the Company’s unaudited stockholders’ equity balance as of the date of
the filing of this Current Report on Form 8-K/A, the Company has prepared a summary pro forma presentation of stockholders’
equity giving effect to the completed transactions discussed above (but excluding any proceeds from the anticipated second closing under the Purchase Agreement). The pro forma information is based on
management’s current estimates and assumptions, is presented for illustrative purposes only, and should not be regarded as indicative
of the Company’s future financial condition or results of operations.
DNA X, INC.
$ in thousands
Stockholders’ Equity
Q1 2026
Q2 2026
July 9th
(actual)
(est.)
(est.)
Net income (loss)
6,340
(1,530 )
(147 )
Beginning Stockholders’ Equity
(7,955 )
(983 )
(1,550 )
Adjustments
Financing
2,446
Note Conversion
3,049
Reclass redeemable shares to equity
963
Remeasurement of stock redemption value
328
Add back for Stock-based Compensation
304
Ending Stockholders’ Equity
$ (983 )
$ (1,550 )
$ 3,798
Cautionary
Note Regarding Forward Looking Statements
This
current report and other related materials may contain a number of “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995, as amended, including statements regarding the Company’s expectation about any
or all of the following: anticipated benefits of and activities under the Transaction and the timing and certainty of completion of the
Transaction, and the Company’s use of proceeds from the Transaction. Forward-looking statements can be identified by terms such
as “will,” “intent,” “expect,” “plan,” “potential,” “would” or
similar expressions and the negative of those terms. The Company has based these forward-looking statements largely on its current expectations
and projections about future events and financial trends that it believes may affect its business, financial condition and results of
operations. Although the Company believes that such statements are based on reasonable assumptions, forward-looking statements are neither
promises nor guarantees and they are necessarily subject to a high degree of uncertainty and risk. Because forward-looking statements
are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond the Company’s
control, you should not rely on these forward-looking statements as predictions of future events. These risks and uncertainties include,
among others, those risk and uncertainties described under the heading “Risk Factors” in the Company’s Annual Report
on Form 10-K filed with the SEC on April 15, 2026, and in any other filings made by the Company with the U.S. Securities and Exchange
Commission, which are available at www.sec.gov. Existing and prospective investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation or undertaking to update
or revise any forward-looking statements contained in this current report, other than to the extent required by law.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
DNA
X, INC.
Date:
July 9, 2026
By:
/s/
Clayton Crolius
Name:
Clayton
Crolius
Title:
Chief
Financial Officer
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 17
v3.26.1
Cover
Jun. 29, 2026
Cover [Abstract]
Document Type
8-K/A
Amendment Flag
true
Amendment Description
This
Current Report on Form 8-K/A amends the Current Report on Form 8-K filed by DNA X, Inc. (the “Company”) with the Securities
and Exchange Commission on July 2, 2026 (the “Original 8-K”). This Form 8-K/A is being filed for the purpose of updating
the disclosure under Items 3.02, 3.03 and 5.03 of the Original 8-K and providing additional information relating to the Transaction under
Item 8.01 hereof.
Document Period End Date
Jun. 29, 2026
Current Fiscal Year End Date
--12-31
Entity File Number
001-38907
Entity Registrant Name
DNA
X, Inc.
Entity Central Index Key
0001178697
Entity Tax Identification Number
94-3336783
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
4445
Eastgate Mall
Entity Address, Address Line Two
Suite 200
Entity Address, City or Town
San
Diego
Entity Address, State or Province
CA
Entity Address, Postal Zip Code
92121
City Area Code
(661)
Local Phone Number
618-7580
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common
Stock, par value $0.001 per share
Trading Symbol
SONM
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
X
- Definition
Description of changes contained within amended document.
+ References
No definition available.
+ Details
Name:
dei_AmendmentDescription
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details
Name:
dei_CurrentFiscalYearEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:gMonthDayItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration